Bakterie wielolekooporne stwarzają realne ryzyko rozwoju trudnych do powstrzymania epidemii. Rozwój antybiotykoodporności zagraża zdrowiu i bezpieczeństwu pacjentów we wszystkich placówkach opieki medycznej w Europie. W 2015 roku stwierdzono znaczący wzrost odsetka oporności na wankomycynę wśród bakterii K. pneumoniae i E.coli. (Biuletyn NPOA 3/2016) Pojawienie się bakterii niewrażliwych na antybiotyki należące do wielu klas terapeutycznych wzbudza...
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
